Announcement • Apr 30
Wuxi Life International Holdings Group Limited, Annual General Meeting, Jun 25, 2026 Wuxi Life International Holdings Group Limited, Annual General Meeting, Jun 25, 2026, at 15:00 China Standard Time. Location: units 5906-12, 59/f, the center, 99 queens road central, Hong Kong Reported Earnings • Apr 02
Full year 2025 earnings released: EPS: HK$0.025 (vs HK$0.017 loss in FY 2024) Full year 2025 results: EPS: HK$0.025 (up from HK$0.017 loss in FY 2024). Revenue: HK$94.6m (up 65% from FY 2024). Net income: HK$10.1m (up HK$14.2m from FY 2024). Profit margin: 11% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Mar 22
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Shareholders have been diluted in the past year (20% increase in shares outstanding). Announcement • Mar 18
Wuxi Life International Holdings Group Limited to Report Fiscal Year 2025 Results on Mar 31, 2026 Wuxi Life International Holdings Group Limited announced that they will report fiscal year 2025 results on Mar 31, 2026 New Risk • Jan 07
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding). Announcement • Nov 29
Wuxi Life International Holdings Group Limited Announces Board Changes, Effective 1 December 2025 The Board of directors of Wuxi Life International Holdings Group Limited announced that with effect from 1 December 2025: (1) Ms. Guan Xiuying, has resigned as a non-executive Director of the Company in order to devote more time to her other business commitments; and (2) Ms. Yan Dandan has been appointed as a non-executive Director of the Company. BIOGRAPHY OF MS. YAN: Ms. Yan, aged 38, graduated from Jinhua Polytechnic () with a major in landscape technology (planning and design) in 2008. She has over 10 years' management experience in business operation across several industries in the People's Republic of China, including apparel retailing, catering and building materials wholesale. Ms. Yan is currently the owner of a shop which engaged in retail of cosmetic products. New Risk • Nov 05
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (15% average weekly change). Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Significant insider selling over the past 3 months (HK$30m sold). Market cap is less than US$100m (HK$710.1m market cap, or US$91.3m). Recent Insider Transactions • Oct 15
Executive Chairman of the Board recently sold HK$15m worth of stock On the 6th of October, Guanzhou Liu sold around 21m shares on-market at roughly HK$0.68 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth HK$16m. Guanzhou has been a net seller over the last 12 months, reducing personal holdings by HK$57m. Recent Insider Transactions • Oct 05
Executive Chairman of the Board recently sold HK$16m worth of stock On the 2nd of October, Guanzhou Liu sold around 23m shares on-market at roughly HK$0.68 per share. This transaction amounted to 10% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Guanzhou has been a net seller over the last 12 months, reducing personal holdings by HK$43m. New Risk • Sep 27
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (HK$352.8m market cap, or US$45.3m). Announcement • Sep 25
Wuxi Life International Holdings Group Limited has completed a Follow-on Equity Offering in the amount of HKD 45.051456 million. Wuxi Life International Holdings Group Limited has completed a Follow-on Equity Offering in the amount of HKD 45.051456 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 76,358,400
Price\Range: HKD 0.59
Transaction Features: Subsequent Direct Listing Reported Earnings • Aug 31
First half 2025 earnings released: EPS: HK$0.006 (vs HK$0.023 in 1H 2024) First half 2025 results: EPS: HK$0.006 (down from HK$0.023 in 1H 2024). Revenue: HK$28.1m (down 24% from 1H 2024). Net income: HK$1.83m (down 38% from 1H 2024). Profit margin: 6.5% (down from 8.0% in 1H 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 66% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Aug 30
Wuxi Life International Holdings Group Limited has filed a Follow-on Equity Offering in the amount of HKD 45.051456 million. Wuxi Life International Holdings Group Limited has filed a Follow-on Equity Offering in the amount of HKD 45.051456 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 76,358,400
Price\Range: HKD 0.59
Transaction Features: Subsequent Direct Listing Announcement • Aug 23
Wuxi Life International Holdings Group Limited has withdrawn its Follow-on Equity Offering in the amount of HKD 13.99904 million. Wuxi Life International Holdings Group Limited has withdrawn its Follow-on Equity Offering in the amount of HKD 13.99904 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 25,452,800
Price\Range: HKD 0.55
Discount Per Security: HKD 0.011
Transaction Features: Subsequent Direct Listing Announcement • Aug 22
Wuxi Life International Holdings Group Limited has filed a Follow-on Equity Offering in the amount of HKD 13.99904 million. Wuxi Life International Holdings Group Limited has filed a Follow-on Equity Offering in the amount of HKD 13.99904 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 25,452,800
Price\Range: HKD 0.55
Discount Per Security: HKD 0.011
Transaction Features: Subsequent Direct Listing Announcement • Aug 15
Wuxi Life International Holdings Group Limited to Report First Half, 2025 Results on Aug 28, 2025 Wuxi Life International Holdings Group Limited announced that they will report first half, 2025 results on Aug 28, 2025 Announcement • Jul 11
Wuxi Life International Holdings Group Limited, Annual General Meeting, Aug 26, 2025 Wuxi Life International Holdings Group Limited, Annual General Meeting, Aug 26, 2025, at 15:00 China Standard Time. Location: units 5906-12, 59/f, the center, 99 queen`s road central., Hong Kong Reported Earnings • Jul 02
Full year 2024 earnings released: HK$0.017 loss per share (vs HK$0.091 loss in FY 2023) Full year 2024 results: HK$0.017 loss per share (improved from HK$0.091 loss in FY 2023). Revenue: HK$57.3m (up 134% from FY 2023). Net loss: HK$4.09m (loss narrowed 65% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 89% per year, which means it is well ahead of earnings. Board Change • Jul 02
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Non-executive Director Qiankun Xia was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Announcement • May 20
Wuxi Life International Holdings Group Limited to Report Fiscal Year 2024 Results on May 30, 2025 Wuxi Life International Holdings Group Limited announced that they will report fiscal year 2024 results at 4:00 PM, China Standard Time on May 30, 2025 Buy Or Sell Opportunity • Mar 20
Now 33% overvalued after recent price rise Over the last 90 days, the stock has risen 110% to HK$1.68. The fair value is estimated to be HK$1.27, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 29%. Announcement • Mar 18
Wuxi Life International Holdings Group Limited to Report Fiscal Year 2024 Results on Mar 28, 2025 Wuxi Life International Holdings Group Limited announced that they will report fiscal year 2024 results on Mar 28, 2025 New Risk • Feb 25
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Negative equity (-HK$1.6m). Shareholders have been substantially diluted in the past year (200% increase in shares outstanding). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Significant insider selling over the past 3 months (HK$37m sold). Market cap is less than US$100m (HK$458.2m market cap, or US$58.9m). Recent Insider Transactions • Dec 20
Executive Chairman of the Board recently sold HK$6.6m worth of stock On the 17th of December, Guanzhou Liu sold around 10m shares on-market at roughly HK$0.63 per share. This transaction amounted to 4.3% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite the recent sale, Guanzhou has been a net buyer over the last 12 months, purchasing a net total of HK$9.1m worth of shares. New Risk • Dec 05
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 19% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Negative equity (-HK$1.6m). Shareholders have been substantially diluted in the past year (200% increase in shares outstanding). Minor Risks Significant insider selling over the past 3 months (HK$8.2m sold). Market cap is less than US$100m (HK$309.3m market cap, or US$39.7m). Recent Insider Transactions • Nov 30
Executive Chairman of the Board recently sold HK$1.2m worth of stock On the 27th of November, Guanzhou Liu sold around 3m shares on-market at roughly HK$0.41 per share. This transaction amounted to 1.2% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth HK$5.1m. Despite the recent sale, Guanzhou has been a net buyer over the last 12 months, purchasing a net total of HK$20m worth of shares. New Risk • Nov 15
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: HK$5.1m This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Major Risks Negative equity (-HK$1.6m). Shareholders have been substantially diluted in the past year (200% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Significant insider selling over the past 3 months (HK$5.1m sold). Market cap is less than US$100m (HK$114.5m market cap, or US$14.7m). Recent Insider Transactions • Oct 28
Executive Chairman of the Board recently sold HK$5.1m worth of stock On the 24th of October, Guanzhou Liu sold around 23m shares on-market at roughly HK$0.23 per share. This transaction amounted to 8.1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite the recent sale, Guanzhou has been a net buyer over the last 12 months, purchasing a net total of HK$23m worth of shares. Announcement • Sep 26
Liu Guanzhou completed the acquisition of 2.89% stake in Wuxi Life International Holdings Group Limited (SEHK:8148) for HKD 1.33 million. Liu Guanzhou proposed to make a mandatory unconditional cash offer to acquire the remaining 29.42% stake in Wuxi Life International Holdings Group Limited (SEHK:8148) for approximately HKD 14 million on August 14, 2024. A cash consideration valued at HKD 0.12 per share will be paid by the Offeror. A total of 112,333,000 Offer Shares are subject to the Offer. In the event that the Offer is accepted in full by the Independent Shareholders, the aggregate amount payable by the Offeror under the Offer will be HKD 13,479,960. The Offeror and parties acting in concert will hold interest in an aggregate of 269,459,000 Shares, comprising 37,000,000 Shares held by the Offeror and 232,459,000 Rights Shares (subject to the Final Allocation) to be issued to the Offeror upon completion of the Rights Issue, representing approximately 70.58% of the total issued shares capital of the Company as enlarged by the issue of 254,528,000 Rights Shares. Accordingly, the Offeror is required to make a mandatory unconditional cash offer. Immediately following completion of the Rights Issue, the Company has 381,792,000 Shares in issue and there is no outstanding options, warrants, derivatives or securities convertible or exchangeable into Shares or other relevant securities.
The Offeror intends to finance the Offer by the Facility granted by Emperor Securities to the Offeror pursuant to the Facility Agreement. A loan facility of up to HK$14.7 million granted by Emperor Securities to the Offeror. The Offeror intends the Company to remain listed on the Stock Exchange. The Independent Board Committee, comprising Li Hui Ling, Fu Yan Ming and Lam Yuen Man Maria, has been established to advise the Independent Shareholders in relation to the terms and conditions of the Offer, in particular as to whether the Offer is fair and reasonable and as to acceptance of the Offer. The deal is expected to be completed on September 25, 2024.
Emperor Corporate Finance has been appointed as the financial adviser to the Offeror in respect of the Offer and is satisfied that sufficient financial resources are available to the Offeror to satisfy full acceptance of the Offer. Lego Corporate Finance Limited acted as a financial advisor to Wuxi Life International Holdings Group Limited.
Liu Guanzhou completed the acquisition of 2.89% stake in Wuxi Life International Holdings Group Limited (SEHK:8148) for HKD 1.33 million on September 25, 2024. 11,051,600 shares were tendered during offer period. the Offeror and parties acting in concert with him are interested in an aggregate of 280,509,750 Shares, representing approximately 73.47% of the entire issued share capital of Wuxi Life International Holdings Group. Announcement • Aug 30
Wuxi Life International Holdings Group Limited Announces Company Secretary Changes, Effective 1 September 2024 The board of Wuxi Life International Holdings Group Limited announced the following change with effect from 1 September 2024: Mr. Hui Hung Kwan has resigned as the company secretary of the Company and ceased to act as an authorised representative of the Company; and Mr. Lee Cheuk Man has been appointed as the company secretary of the Company and an authorised representative of the Company. Mr. Lee is a member of the Hong Kong Institute of Certified Public Accountants. Mr. Lee has over 25 years of experience in auditing, financial management and accounting in various companies listed on the main board of the Stock Exchange. Prior to joining the Company, he had served as company secretary of several companies listed on the main board and GEM of the Stock Exchange. He has ample experiences in the company secretarial field and in handling corporate governance and compliance matters for listed companies. Recent Insider Transactions • Aug 21
Executive Chairman of the Board recently bought HK$28m worth of stock On the 15th of August, Guanzhou Liu bought around 232m shares on-market at roughly HK$0.12 per share. This transaction increased Guanzhou's direct individual holding by 6x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Guanzhou's only on-market trade for the last 12 months. New Risk • Aug 17
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 200% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-HK$1.6m). Shareholders have been substantially diluted in the past year (200% increase in shares outstanding). Market cap is less than US$10m (HK$51.2m market cap, or US$6.56m). Announcement • Aug 16
Liu Guanzhou proposed to make a mandatory unconditional cash offer to acquire the remaining 29.42% stake in Wuxi Life International Holdings Group Limited (SEHK:8148) for approximately HKD 14 million. Liu Guanzhou proposed to make a mandatory unconditional cash offer to acquire the remaining 29.42% stake in Wuxi Life International Holdings Group Limited (SEHK:8148) for approximately HKD 14 million on August 14, 2024. A cash consideration valued at HKD 0.12 per share will be paid by the Offeror. A total of 112,333,000 Offer Shares are subject to the Offer. In the event that the Offer is accepted in full by the Independent Shareholders, the aggregate amount payable by the Offeror under the Offer will be HKD 13,479,960. The Offeror and parties acting in concert will hold interest in an aggregate of 269,459,000 Shares, comprising 37,000,000 Shares held by the Offeror and 232,459,000 Rights Shares (subject to the Final Allocation) to be issued to the Offeror upon completion of the Rights Issue, representing approximately 70.58% of the total issued shares capital of the Company as enlarged by the issue of 254,528,000 Rights Shares. Accordingly, the Offeror is required to make a mandatory unconditional cash offer. Immediately following completion of the Rights Issue, the Company has 381,792,000 Shares in issue and there is no outstanding options, warrants, derivatives or securities convertible or exchangeable into Shares or other relevant securities.
The Offeror intends to finance the Offer by the Facility granted by Emperor Securities to the Offeror pursuant to the Facility Agreement. A loan facility of up to HK$14.7 million granted by Emperor Securities to the Offeror. The Offeror intends the Company to remain listed on the Stock Exchange. The Independent Board Committee, comprising Li Hui Ling, Fu Yan Ming and Lam Yuen Man Maria, has been established to advise the Independent Shareholders in relation to the terms and conditions of the Offer, in particular as to whether the Offer is fair and reasonable and as to acceptance of the Offer.
Emperor Corporate Finance has been appointed as the financial adviser to the Offeror in respect of the Offer and is satisfied that sufficient financial resources are available to the Offeror to satisfy full acceptance of the Offer. Reported Earnings • Aug 02
First half 2024 earnings released: EPS: HK$0.002 (vs HK$0.015 loss in 1H 2023) First half 2024 results: EPS: HK$0.002 (up from HK$0.015 loss in 1H 2023). Revenue: HK$36.7m (up 176% from 1H 2023). Net income: HK$2.96m (up HK$4.85m from 1H 2023). Profit margin: 8.0% (up from net loss in 1H 2023). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. New Risk • Jul 24
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 200% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-HK$4.6m). Shareholders have been substantially diluted in the past year (200% increase in shares outstanding). Market cap is less than US$10m (HK$59.2m market cap, or US$7.58m). Minor Risk Revenue is less than US$5m (HK$24m revenue, or US$3.1m). Announcement • Jul 22
Wuxi Life International Holdings Group Limited to Report First Half, 2024 Results on Aug 02, 2024 Wuxi Life International Holdings Group Limited announced that they will report first half, 2024 results on Aug 02, 2024 New Risk • Jun 21
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Negative equity (-HK$4.6m). Market cap is less than US$10m (HK$3.31m market cap, or US$424.1k). Minor Risk Revenue is less than US$5m (HK$24m revenue, or US$3.1m). Announcement • Apr 10
Wuxi Life International Holdings Group Limited, Annual General Meeting, May 02, 2024 Wuxi Life International Holdings Group Limited, Annual General Meeting, May 02, 2024, at 11:00 China Standard Time. Location: Portion 2, 12/F.,The Center, 99 Queen's Road Central, Hong Kong Honk Kong Hong Kong Agenda: To discuss an order being made by the Grand Court of the Cayman Islands confirming the Capital Reduction and compliance with any condition which the Court may impose in relation to the Capital Reduction, registration by the Registrar of Companies of the Cayman Islands of a copy of the order of the Court confirming the Capital Reduction and the minute approved by the Court containing the particulars required under the Companies Act, Cap. 22 of the Cayman Islands in respect of the Capital Reduction, the Listing Committee of the Stock Exchange granting approval for the listing of, and permission to deal in, the Adjusted Shares; to approve the Capital re-organization; and to approve the Rights Issue and the transactions contemplated thereunder. New Risk • Mar 30
New major risk - Negative shareholders equity The company has negative equity. Total equity: -HK$4.6m This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Negative equity (-HK$4.6m). Market cap is less than US$10m (HK$26.7m market cap, or US$3.42m). Minor Risk Revenue is less than US$5m (HK$24m revenue, or US$3.1m). Reported Earnings • Mar 30
Full year 2023 earnings released: HK$0.91 loss per share (vs HK$0.017 loss in FY 2022) Full year 2023 results: HK$0.91 loss per share. Revenue: HK$24.5m (up 14% from FY 2022). Net loss: HK$11.6m (loss narrowed 46% from FY 2022). Announcement • Mar 16
Wuxi Life International Holdings Group Limited to Report Fiscal Year 2023 Results on Mar 28, 2024 Wuxi Life International Holdings Group Limited announced that they will report fiscal year 2023 results on Mar 28, 2024 Announcement • Nov 30
Wuxi Life International Holdings Group Limited Announces Change of Executive Director Wuxi Life International Holdings Group Limited announced the appointment of Ms. Liu Xingmei as an executive Director of the Company with effect from 30 November 2023. Ms. Liu, aged 34, has over 7 years of experience in internet micro-business brand management, and over 2 years of experience in advertising e-commerce operation and management, including rich sales channels and business network in the People's Republic of China. Ms. Liu has won several awards in the e-commerce industry. Ms. Liu currently leads an e-commerce team of approximately 20,000 people in the advertising e-commerce business. The Board would like to announce that Mr. Chung Man Lai ("Mr. Chung") has tendered his resignation as an executive Director of the Company with effect from 30 November 2023 as he desires to devote more time to his other business commitments. Mr. Chung has confirmed that he has no disagreement with the Board and there are no matters in relation to his resignation which should be brought to the attention of the shareholders of the Company (the "Shareholders"). The Board is also not aware of any such matters in relation to his resignation that need to be bought to the attention of the Shareholders. Reported Earnings • Nov 11
Third quarter 2023 earnings released: EPS: HK$0 (vs HK$0.001 loss in 3Q 2022) Third quarter 2023 results: EPS: HK$0 (improved from HK$0.001 loss in 3Q 2022). Revenue: HK$7.35m (up 75% from 3Q 2022). Net loss: HK$284.0k (loss narrowed 73% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth. Announcement • Nov 01
Wuxi Life International Holdings Group Limited to Report Q3, 2023 Results on Nov 10, 2023 Wuxi Life International Holdings Group Limited announced that they will report Q3, 2023 results on Nov 10, 2023 New Risk • Aug 14
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -HK$6.5m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-HK$6.5m free cash flow). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Revenue is less than US$5m (HK$22m revenue, or US$2.9m). Market cap is less than US$100m (HK$110.7m market cap, or US$14.2m). Reported Earnings • Aug 13
Second quarter 2023 earnings released: HK$0.002 loss per share (vs HK$0 in 2Q 2022) Second quarter 2023 results: HK$0.002 loss per share (further deteriorated from HK$0 in 2Q 2022). Revenue: HK$4.05m (down 34% from 2Q 2022). Net loss: HK$2.95m (loss widened HK$2.93m from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 52% per year, which means it is significantly lagging earnings growth. Announcement • Jul 29
Aurum Pacific (China) Group Limited to Report First Half, 2023 Results on Aug 11, 2023 Aurum Pacific (China) Group Limited announced that they will report first half, 2023 results on Aug 11, 2023 Reported Earnings • May 14
First quarter 2023 earnings released: EPS: HK$0.001 (vs HK$0 in 1Q 2022) First quarter 2023 results: EPS: HK$0.001 (up from HK$0 in 1Q 2022). Revenue: HK$9.28m (up 51% from 1Q 2022). Net income: HK$1.06m (up 395% from 1Q 2022). Profit margin: 11% (up from 3.5% in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 08
Full year 2022 earnings released: HK$0.017 loss per share (vs HK$0.005 loss in FY 2021) Full year 2022 results: HK$0.017 loss per share (further deteriorated from HK$0.005 loss in FY 2021). Revenue: HK$21.4m (up 5.8% from FY 2021). Net loss: HK$21.3m (loss widened 237% from FY 2021). Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Announcement • Feb 15
Aurum Pacific (China) Group Limited Appoints Li Hui Ling as A Non-Executive Director Aurum Pacific (China) Group Limited announced the appointment of Ms. Li Hui Ling as a non-executive Director of the Company with effect from 14 February 2023. Ms. Li, aged 41, possesses over 17 years of experience in software and digital marketing and finance related duties. Ms. Li is the founder of several private companies which are engaging in software business development, digital marketing business development and website business development. In the course of her career, Ms. Li has been the chief marketing officer, the general manager and the chairman of the board. Board Change • Nov 16
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. Executive Director Desmond Chung is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Nov 13
Third quarter 2022 earnings released: HK$0.001 loss per share (vs HK$0.003 loss in 3Q 2021) Third quarter 2022 results: HK$0.001 loss per share (improved from HK$0.003 loss in 3Q 2021). Revenue: HK$4.21m (down 23% from 3Q 2021). Net loss: HK$1.06m (loss narrowed 72% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Announcement • Nov 02
Aurum Pacific (China) Group Limited to Report Q3, 2022 Results on Nov 11, 2022 Aurum Pacific (China) Group Limited announced that they will report Q3, 2022 results at 4:00 PM, China Standard Time on Nov 11, 2022 Reported Earnings • Aug 15
Second quarter 2022 earnings released: EPS: HK$0 (vs HK$0.004 loss in 2Q 2021) Second quarter 2022 results: EPS: HK$0 (up from HK$0.004 loss in 2Q 2021). Revenue: HK$6.12m (up 61% from 2Q 2021). Net loss: HK$14.0k (loss narrowed 100% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings. Announcement • Aug 03
Aurum Pacific (China) Group Limited to Report First Half, 2022 Results on Aug 12, 2022 Aurum Pacific (China) Group Limited announced that they will report first half, 2022 results on Aug 12, 2022 Reported Earnings • May 16
First quarter 2022 earnings released: EPS: HK$0 (vs HK$0.017 loss in 1Q 2021) First quarter 2022 results: EPS: HK$0 (up from HK$0.017 loss in 1Q 2021). Revenue: HK$6.16m (down 9.0% from 1Q 2021). Net income: HK$213.0k (up HK$21.3m from 1Q 2021). Profit margin: 3.5% (up from net loss in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 49% per year, which means it is significantly lagging earnings. Announcement • May 12
Aurum Pacific (China) Group Limited Provides Earnings Guidance for the Three Months Ended March 31, 2022 Aurum Pacific (China) Group Limited provided earnings guidance for the three months ended March 31, 2022. For the year, the company expects that there will be a turnaround in its results from a loss attributable to the owners of the Company of approximately HKD 21,076,000 for the three months ended March 31, 2021 to a profit of not more than HKD 240,000 for the three months ended March 31, 2022. Board Change • Apr 27
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. Executive Director Desmond Chung is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Announcement • Mar 31
Aurum Pacific (China) Group Limited, Annual General Meeting, May 27, 2022 Aurum Pacific (China) Group Limited, Annual General Meeting, May 27, 2022, at 11:00 China Standard Time. Agenda: To receive and consider the audited consolidated financial statements and the reports of the Directors and of the auditors of the Company for the year ended 31 December 2021; to re-elect directors; to authorize the board of directors to fix the directors's remuneration; to re-appoint Baker Tilly Hong Kong Limited as the auditor of the Company and to authorise the board of directors of the Company to fix their remuneration; to grant the general mandate to the Directors to issue, allot and otherwise deal with the Shares; to grant the general mandate to the Directors to repurchase the Shares; and to extend the general mandate granted to the Directors pur to issue additional shares of the Company. Board Change • Nov 01
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. Executive Director Desmond Chung is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Executive Departure • Oct 07
Independent Non-Executive Director Man Chun Leung has left the company On the 1st of October, Man Chun Leung's tenure as Independent Non-Executive Director ended after 5.6 years in the role. We don't have any record of a personal shareholding under Man Chun's name. A total of 10 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Reported Earnings • Aug 18
Second quarter 2021 earnings released: HK$0.004 loss per share (vs HK$0.005 loss in 2Q 2020) Second quarter 2021 results: Net loss: HK$4.91m (loss narrowed 27% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has fallen by 52% per year, which means it is performing significantly worse than earnings. Executive Departure • Jun 03
Executive Director Yik Chow has left the company On the 1st of June, Yik Chow's tenure as Executive Director ended after 1.2 years in the role. We don't have any record of a personal shareholding under Yik's name. A total of 10 executives have left over the last 12 months. Executive Departure • Jun 03
Compliance Officer Tong Yao has left the company On the 27th of May, Tong Yao's tenure as Compliance Officer ended after less than a year in the role. We don't have any record of a personal shareholding under Tong's name. A total of 10 executives have left over the last 12 months. Reported Earnings • May 15
First quarter 2021 earnings released: HK$0.017 loss per share (vs HK$0.004 loss in 1Q 2020) First quarter 2021 results: Net loss: HK$21.1m (loss widened 366% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has fallen by 50% per year, which means it is performing significantly worse than earnings. Executive Departure • Apr 21
Executive Director has left the company On the 14th of April, Cha Hwa Chong's tenure as Executive Director ended after less than a year in the role. We don't have any record of a personal shareholding under Cha Hwa's name. A total of 9 executives have left over the last 12 months. Executive Departure • Apr 21
Company Secretary has left the company On the 14th of April, Lai Ming Leung's tenure as Company Secretary ended after less than a year in the role. We don't have any record of a personal shareholding under Lai Ming's name. A total of 9 executives have left over the last 12 months. Reported Earnings • Mar 25
Full year 2020 earnings released: HK$0.056 loss per share (vs HK$0.048 loss in FY 2019) Full year 2020 results: Net loss: HK$71.6m (loss widened 17% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has fallen by 51% per year, which means it is performing significantly worse than earnings. Announcement • Mar 12
Aurum Pacific (China) Group Limited to Report Fiscal Year 2020 Results on Mar 23, 2021 Aurum Pacific (China) Group Limited announced that they will report fiscal year 2020 results on Mar 23, 2021 Executive Departure • Mar 09
Independent Non-Executive Director has left the company On the 1st of March, Lee Lam's tenure as Independent Non-Executive Director ended after 2.2 years in the role. We don't have any record of a personal shareholding under Lee's name. A total of 8 executives have left over the last 12 months. Executive Departure • Mar 09
Company Secretary has left the company On the 2nd of March, Wing Kwan Yuen's tenure as Company Secretary ended after 2.8 years in the role. We don't have any record of a personal shareholding under Wing Kwan's name. A total of 8 executives have left over the last 12 months. Announcement • Mar 05
Aurum Pacific (China) Group Limited Announces Board Changes The Board of Aurum Pacific (China) Group Limited announced that Ms. Yuen Wing Kwan has resigned as a joint company secretary of the Company and ceased to act as an authorised representative of the Company all with effect from 2 March 2021. Following the resignation of Ms. Yuen, Ms. Leung Lai Ming, the other joint company secretary of the Company, will remain in office and act as the sole company secretary of the Company. The Board further announces that Mr. Chow Yik, the executive Director has been appointed as the Authorised Representative in replacement of Ms. Yuen with effect from 2 March 2021. Announcement • Mar 04
Aurum Pacific (China) Group Limited Announces Resignation of Dr. Lee G. Lam as Independent Non-Executive Director and Member of the Audit Committee Aurum Pacific (China) Group Limited board announced that Dr. Lee G. Lam has tendered his resignation as an independent non-executive Director and a member of the audit committee of the company all with effect from 1 March 2021 as he desires to devote more time to his other business commitments. Dr. Lam has confirmed that he has no disagreement with the Board and there are no matters in relation to his resignation which should be brought to the attention of the shareholders of the company. Following the resignation of Dr. Lam, the company does not have at least three independent non-executive Directors under Rule 5.05 of the GEM Listing Rules and the audit committee of the company does not comprise a minimum of three members under Rule 5.28 of the GEM Listing Rules. Announcement • Dec 31
Aurum Pacific (China) Group Limited Announces Resignation of Directors and Changes of Composition of Audit Committee,Nomination Committee and Remuneration Committee The Board of Aurum Pacific (China) Group Limited announced that Mr. Zheng Yongqiang ("Mr. Zheng") has tendered his resignation as a non-executive Director of the Company with effect from 1 January 2021 as he desires to devote more time to his other business commitments. The Board announced that Mr. Fok Kin Fung Eric ("Mr. Fok") has tendered his resignation as an independent non-executive Director and a member of each of the audit committee, nomination committee and remuneration committee all with effect from 1 January 2021 as he desires to devote more time to his other business commitments. Following the resignation of Mr. Fok, Ms. Lam Yuen Man Maria, an independent non- executive Director, has been appointed as a member of each of the audit committee, nomination committee and remuneration committee of the Company in replacement of Mr. Fok all with effect from 1 January 2021. Announcement • Dec 10
Aurum Pacific (China) Group Limited Appoints Yao Tong as Executive Director, Member of the Remuneration Committee and Compliance Officer The Board of Aurum Pacific (China) Group Limited announced the appointment of Mr. Yao Tong ("Mr. Yao") as an executive Director, a member of the remuneration committee and compliance officer of the Company all with effect from 7 December 2020. Prior to joining the Board, Mr. Yao was the business manager of Shanghai DZH Limited. Announcement • Dec 04
Aurum Pacific (China) Group Limited Announces Resignation of Tsui Wing Tak as Executive Director, Member of the Remuneration Committee and as Compliance Officer Aurum Pacific (China) Group Limited announced that Mr. Tsui Wing Tak ("Mr. Tsui") has tendered his resignation as an executive Director and a member of the remuneration committee of the Company with effect from 3 December 2020 as he desires to devote more time to his other business and family commitments. Upon his resignation, Mr. Tsui will also cease to be the compliance officer of the Company. Mr. Tsui has confirmed that he has no disagreement with the Board and there are no matters in relation to his resignation which should be brought to the attention of the shareholders of the Company (the "Shareholders"). Announcement • Nov 03
Aurum Pacific (China) Group Limited to Report Q3, 2020 Results on Nov 12, 2020 Aurum Pacific (China) Group Limited announced that they will report Q3, 2020 results on Nov 12, 2020 Announcement • Oct 15
Aurum Pacific (China) Group Limited Announces Management Changes Aurum Pacific (China) Group Limited announced that Mr. Chong Cha Hwa has been appointed as an executive Director of the company with effect from 14 October 2020. Mr. Chong is currently also an independent non-executive director of China Beidahuang Industry Group Holdings Limited. The Board announced the appointment of Ms. Leung Lai Ming as a joint company secretary of the company with effect from 14 October 2020. Following the appointment of Ms. Leung, Ms. Yuen Wing Kwan, the existing company secretary of the Company, will act as the other joint company secretary of the company. Ms. Leung has extensive experience in company secretarial practice gained from public companies in Hong Kong and is familiar with the corporate governance practice under the Listing Rules and Hong Kong Companies Ordinance. The Board further announced that Mr. Tsui Wing Tak has resigned as an authorized representative of the company under Rule 5.24 of the GEM Listing Rules with effect from 14 October 2020, and he shall remain as an executive Director of the company. Mr. Chong Cha Hwa has also been appointed as an Authorised Representative with effect from 14 October 2020. Announcement • Aug 01
Aurum Pacific (China) Group Limited to Report First Half, 2020 Results on Aug 14, 2020 Aurum Pacific (China) Group Limited announced that they will report first half, 2020 results on Aug 14, 2020 
